• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死后早期再发心肌梗死的特征和结局。

Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction.

机构信息

Cleveland Clinic Heart, Vascular and Thoracic Institute Cleveland OH.

Cleveland Clinic Heart, Vascular and Thoracic Institute Center for Healthcare Delivery Innovation Cleveland OH.

出版信息

J Am Heart Assoc. 2021 Aug 17;10(16):e019270. doi: 10.1161/JAHA.120.019270. Epub 2021 Aug 2.

DOI:10.1161/JAHA.120.019270
PMID:34333986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8475017/
Abstract

Background We aimed to understand the characteristics and outcomes of patients readmitted with a recurrent myocardial infarction (RMI) within 90 days of discharge after an acute myocardial infarction (early RMI). Methods and Results We analyzed the timing of reinfarction, etiology, and outcome for all patients admitted with an early RMI within 90 days of discharge after an acute myocardial infarction between January 1, 2010 and January 1, 2017. We identified 6626 admissions for acute myocardial infarction (index myocardial infarction) which led to 168 cases of RMI within 90 days of discharge. The mean patient age was 65.1±13.1 years, and 37% were women. The 90-day probability of readmission with an early RMI was 2.5%. Black race, medical management, higher troponin T, and shorter length of stay were independent predictors of early RMI. Medically managed group had a higher risk for early RMI compared with percutaneous coronary intervention (=0.04) or coronary artery bypass grafting (=0.2). Predominant mechanisms for reinfarction were stent thrombosis (17%), disease progression (12%), and unchanged coronary artery disease (11%). At 5 years, the all-cause mortality rate for patients with an early RMI was 49% (95% CI, 40%-57%) compared with 22% (95% CI, 21%-23%) for patients without an early RMI (<0.0001). Conclusions Early RMI is a life-threatening condition with nearly 50% mortality within 5 years. Stent-related events and progression in coronary artery disease account for most early RMI. Medication compliance, aggressive risk factor management, and care transitions should be the cornerstone in preventing early RMI.

摘要

背景 我们旨在了解急性心肌梗死(AMI)后 90 天内因复发性心肌梗死(RMI)再入院患者的特征和结局。 方法和结果 我们分析了 2010 年 1 月 1 日至 2017 年 1 月 1 日期间所有在 AMI 后 90 天内因 RMI 再入院患者的再梗死时间、病因和结局。我们确定了 6626 例 AMI 住院患者(索引性心肌梗死),其中有 168 例在出院后 90 天内发生 RMI。患者平均年龄为 65.1±13.1 岁,37%为女性。90 天内因早期 RMI 再入院的概率为 2.5%。黑种人、药物治疗、较高的肌钙蛋白 T 和较短的住院时间是早期 RMI 的独立预测因素。与经皮冠状动脉介入治疗(=0.04)或冠状动脉旁路移植术(=0.2)相比,药物治疗组发生早期 RMI 的风险更高。再梗死的主要机制是支架血栓形成(17%)、疾病进展(12%)和不变的冠状动脉疾病(11%)。在 5 年内,早期 RMI 患者的全因死亡率为 49%(95%CI,40%-57%),而无早期 RMI 患者的死亡率为 22%(95%CI,21%-23%)(<0.0001)。 结论 早期 RMI 是一种危及生命的疾病,5 年内死亡率接近 50%。支架相关事件和冠状动脉疾病进展是导致早期 RMI 的主要原因。药物依从性、积极的危险因素管理和医疗过渡期应成为预防早期 RMI 的基石。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/797a5071943c/JAH3-10-e019270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/5b11dd10ac3b/JAH3-10-e019270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/886086ddfda6/JAH3-10-e019270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/797a5071943c/JAH3-10-e019270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/5b11dd10ac3b/JAH3-10-e019270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/886086ddfda6/JAH3-10-e019270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd12/8475017/797a5071943c/JAH3-10-e019270-g002.jpg

相似文献

1
Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction.急性心肌梗死后早期再发心肌梗死的特征和结局。
J Am Heart Assoc. 2021 Aug 17;10(16):e019270. doi: 10.1161/JAHA.120.019270. Epub 2021 Aug 2.
2
The Pt-Cr everolimus-eluting stent with bioabsorbable polymer in the treatment of patients with acute coronary syndromes. Results from the SYNERGY ACS registry.采用含生物可吸收聚合物的铂铬依维莫司洗脱支架治疗急性冠状动脉综合征患者。SYNERGY ACS注册研究结果。
Cardiovasc Revasc Med. 2019 Aug;20(8):705-710. doi: 10.1016/j.carrev.2018.10.019. Epub 2018 Oct 18.
3
Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.在一个大型多中心队列中植入自膨胀式STENTYS支架后的长期临床结果。
Coron Artery Dis. 2017 Nov;28(7):588-596. doi: 10.1097/MCA.0000000000000533.
4
Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.经皮冠状动脉血运重建术后的死亡率:既往心血管危险因素控制与糖尿病患者预后改善
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1195-1204. doi: 10.1002/ccd.26882. Epub 2016 Dec 28.
5
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).伴有非ST段抬高型心肌梗死的糖尿病合并多支冠状动脉疾病患者的血运重建趋势:来自国家心血管数据注册库急性冠状动脉治疗和干预结果网络注册库-遵循指南行动(NCDR ACTION注册库-GWTG)的见解
Circ Cardiovasc Qual Outcomes. 2016 May;9(3):197-205. doi: 10.1161/CIRCOUTCOMES.115.002084. Epub 2016 May 10.
6
Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.接受直接经皮冠状动脉介入治疗的右冠状动脉ST段抬高型心肌梗死患者入院心率与血管造影及临床结局的相关性:HORIZONS-AMI(急性心肌梗死血管重建和支架置入的协调结局)试验
J Am Heart Assoc. 2017 Jul 19;6(7):e006181. doi: 10.1161/JAHA.117.006181.
7
Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry.弥漫性冠状动脉疾病的经皮介入治疗:重叠与单根超长支架技术的比较。来自 OVERLONG 登记研究的结果。
Angiology. 2021 Nov;72(10):979-985. doi: 10.1177/00033197211014686. Epub 2021 May 10.
8
Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome.经皮冠状动脉介入治疗与非 ST 段抬高型急性冠状动脉综合征患者冠状动脉旁路移植术后的药物治疗。
Circ Cardiovasc Interv. 2019 Aug;12(8):e007830. doi: 10.1161/CIRCINTERVENTIONS.119.007830. Epub 2019 Jul 31.
9
Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial.雷帕霉素洗脱钴基合金依维莫司洗脱支架治疗 ST 段抬高型心肌梗死(resolute-STEMI):来自 DAPT-STEMI 试验的预设前瞻性登记研究。
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):706-710. doi: 10.1002/ccd.28376. Epub 2019 Jul 3.
10
Percutaneous Coronary Intervention for Left Main Coronary Disease in New Zealand: National Linkage Study of Characteristics and In-Hospital Outcomes (ANZACS-QI 38).新西兰左主干冠状动脉疾病的经皮冠状动脉介入治疗:特征与住院结局的全国性关联研究(ANZACS-QI 38)
Cardiovasc Revasc Med. 2020 May;21(5):573-579. doi: 10.1016/j.carrev.2019.08.016. Epub 2019 Aug 23.

引用本文的文献

1
Explainable machine learning for predicting ICU mortality in myocardial infarction patients using pseudo-dynamic data.利用伪动态数据进行可解释的机器学习以预测心肌梗死患者的重症监护病房死亡率
Sci Rep. 2025 Jul 31;15(1):27887. doi: 10.1038/s41598-025-13299-3.
2
Effect of a nurse-avatar guided discharge education smartphone application in people after acute coronary syndrome: a randomized controlled trial.护士虚拟化身引导的出院教育智能手机应用程序对急性冠状动脉综合征患者的影响:一项随机对照试验。
Eur Heart J Digit Health. 2025 Apr 16;6(4):772-782. doi: 10.1093/ehjdh/ztaf036. eCollection 2025 Jul.
3
Evaluate gender differences in patients with left main coronary artery disease.

本文引用的文献

1
Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,就诊时肌钙蛋白与院内死亡率的关系。
J Am Heart Assoc. 2019 Oct;8(19):e013551. doi: 10.1161/JAHA.119.013551. Epub 2019 Sep 24.
2
Mechanical, inflammatory, and embolic complications of myocardial infarction: An emergency medicine review.心肌梗死的机械性、炎症性和栓塞性并发症:急诊医学综述。
Am J Emerg Med. 2019 Jun;37(6):1175-1183. doi: 10.1016/j.ajem.2019.04.003. Epub 2019 Apr 8.
3
评估左主干冠状动脉疾病患者的性别差异。
ARYA Atheroscler. 2025;21(1):1-6. doi: 10.48305/arya.2024.42805.2979.
4
Risk stratification analysis of recurrent myocardial infarction in Indian population using inflammatory, lipid, thrombotic and extracellular matrix remodeling markers.使用炎症、脂质、血栓形成和细胞外基质重塑标志物对印度人群复发性心肌梗死进行风险分层分析。
Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202425. doi: 10.21542/gcsp.2024.25.
5
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial.秋水仙碱治疗急性缺血性卒中和短暂性脑缺血发作患者(CHANCE-3)的多中心、双盲、随机、安慰剂对照试验
BMJ. 2024 Jun 26;385:e079061. doi: 10.1136/bmj-2023-079061.
6
Two Strikes: A Case Study of Consecutive St-Elevation Myocardial Infarctions (Stemi) in two Different Coronary Arteries.两次发作:不同冠状动脉连续发生ST段抬高型心肌梗死(STEMI)的病例研究
Eur J Case Rep Intern Med. 2024 Apr 3;11(5):004495. doi: 10.12890/2024_004495. eCollection 2024.
7
Incidence and predictors of recurrent acute coronary syndrome among adult patients with acute coronary syndrome in West Amhara, Ethiopia: a multicenter retrospective follow-up study.埃塞俄比亚阿姆哈拉西部地区成年急性冠状动脉综合征患者复发性急性冠状动脉综合征的发病率及预测因素:一项多中心回顾性随访研究
Front Cardiovasc Med. 2023 Oct 16;10:1234239. doi: 10.3389/fcvm.2023.1234239. eCollection 2023.
8
Acute Coronary Syndrome Presenting during On- and Off-Hours: Is There a Difference in a Tertiary Cardiovascular Center?急性冠状动脉综合征在工作时间和非工作时间就诊:在三级心血管中心有区别吗?
Medicina (Kaunas). 2023 Aug 4;59(8):1420. doi: 10.3390/medicina59081420.
9
Recurrent myocardial infarction and emergency department visits: a retrospective study on the Stockholm Area Chest Pain Cohort.复发性心肌梗死与急诊科就诊:斯德哥尔摩胸痛队列研究的回顾性研究。
Open Heart. 2023 Jun;10(1). doi: 10.1136/openhrt-2022-002206.
10
Risk Factors of Secondary Cardiovascular Events in a Multi-Ethnic Asian Population with Acute Myocardial Infarction: A Retrospective Cohort Study from Malaysia.多民族亚洲急性心肌梗死患者继发性心血管事件的危险因素:一项来自马来西亚的回顾性队列研究。
J Cardiovasc Dev Dis. 2023 Jun 9;10(6):250. doi: 10.3390/jcdd10060250.
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
4
Long-Term Time-Varying Risk of Readmission After Acute Myocardial Infarction.急性心肌梗死后长期时变再入院风险。
J Am Heart Assoc. 2018 Nov 6;7(21):e009650. doi: 10.1161/JAHA.118.009650.
5
Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010-2014.美国 ST 段抬高型心肌梗死患者 30 天再入院率、时间、原因和费用:2010-2014 年全国再入院数据库分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009863. doi: 10.1161/JAHA.118.009863.
6
Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction.预测急性心肌梗死后90天再入院风险的临床模型。
Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e004788. doi: 10.1161/CIRCOUTCOMES.118.004788.
7
Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study.心力衰竭住院患者出院计划的效果:一项前后对照研究。
ESC Heart Fail. 2018 Aug;5(4):657-667. doi: 10.1002/ehf2.12295. Epub 2018 May 14.
8
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.急性心肌梗死后的炎症反应:多种角色,动态作用,以及新的治疗机会。
Pharmacol Ther. 2018 Jun;186:73-87. doi: 10.1016/j.pharmthera.2018.01.001. Epub 2018 Jan 9.
9
Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.现代临床实践中首次心肌梗死后左心室重构的长期预后影响
PLoS One. 2017 Nov 27;12(11):e0188884. doi: 10.1371/journal.pone.0188884. eCollection 2017.
10
Systemic Inflammatory Response Syndrome is an Independent Predictor of One-Year Mortality in Patients with Acute Myocardial Infarction.全身炎症反应综合征是急性心肌梗死患者一年死亡率的独立预测因素。
Acta Cardiol Sin. 2017 Sep;33(5):477-485. doi: 10.6515/acs20170603a.